ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 945

Work Loss in Systemic Lupus Erythematosus, the General Public, and Other Chronic Conditions

S. Sam Lim1, Greg Dennis2, Hong Kan3, Priti M. Jhingran3, Charles T. Molta4, Gaobin Bao5 and Cristina Drenkard6, 1Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, 2Human Genome Sciences, Inc., Rockville, MD, 3GlaxoSmithKline, Research Triangle Park, NC, 4GlaxoSmithKline, Philadelphia, PA, 5Medicine, Emory University, Atlanta, GA, 6Medicine, Div Rheumatology, Emory University, Atlanta, GA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Work Disability and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic lupus erythematosus (SLE) predominantly develops in young groups, when many are establishing themselves in the workforce and can have a devastating impact on employment. We studied the impact of sociodemographic factors on work loss in SLE, the general public, and other major chronic conditions. 

Methods: The Georgians Organized Against Lupus (GOAL) cohort is derived predominantly from the population-based Georgia Lupus Registry and collects annually self-reported measures from validated patients with SLE. The Behavioral Risk Factor Surveillance System (BRFSS) survey samples representative individuals from the general population on self-reported health conditions and behaviors. We studied GOAL SLE participants who lived in the Atlanta metropolitan area surveyed between August 2011 and April 2012, and 4 BRFSS samples (general population and self-reported diabetes, asthma, and cardiovascular disease [CVD]) from the same geographic area, surveyed between 2005-10. The effect of sociodemographic factors on being unemployed/disabled at survey completion in SLE and BRFSS participants aged >18 and <65 was analyzed with logistic regression. We reported the adjusted odds ratios (OR) of being unemployed/disabled for each sociodemographic variable within SLE and 4 BRFSS samples.

Results:

 

SLE

n=630

General

n=6339

Diabetes

n=473

Asthma

n=783

CVD

n=244

Age, mean

45

41

49

38

51

Females %

94

52

51

57

49

Whites %

19

59

51

61

46

Blacks %

81

42

49

39

54

Education ≤high school %

35

23

30

28

34

Unemployed/disabled% (95% CI)

47 (43-50)

12 (11-13)

23 (18-28)

19 (14-23)

33 (25-42)

OR (95% CI) of unemployed/disabled1

Age

(Per 5 year increase)

1.1 (1.0-1.2)

1.1 (1.1-1.2)

1.1 (1.0-1.3)

1.2 (1.1-1.3)

0.9 (0.7-1.2)

Gender

(Male vs Female)

1.2 (0.6-2.4)

1.2 (0.9-1.5)

0.9 (0.5-1.7)

2.0 (1.0-3.9)

1.0 (0.5-2.2)

Race

(Black vs White)

2.7 (1.7-4.3)

1.9 (1.4-2.5)

1.0 (0.6-2.0)

1.7 (0.9-3.2)

1.5 (0.7-3.1)

Marital Status

(Married vs other2)

0.5 (0.4-0.7)

0.5 (0.4-0.6)

0.4 (0.2-0.7)

0.3 (0.2-0.7)

0.2 (0.1-0.4)

Education

(≤High School vs

>High School)

2.1 (1.5-3.0)

3.0 (2.3-3.9)

4.0 (2.2-7.3)

2.9 (1.5-5.7)

2.5 (1.1-5.8)

1 Adjusted by the other sociodemographics

2 never married, separated, divorced, widowed

Conclusion: The burden of unemployment/disability was significantly higher in SLE than in other chronic diseases, even when the mean age of SLE and the education level were similar across groups. Less than 1/3 of individuals with diabetes, asthma and CVD were unemployed, as compared to almost 50% of SLE. Black race was associated with unemployment/disability in SLE and the general population, but not in other chronic diseases. Lower education and not being married increased the risk of unemployment/disability in all groups. Important factors, such as disease severity, treatment response, or access to care in black patients with SLE must be further explored in order to reduce the burden of work loss in SLE.


Disclosure:

S. S. Lim,

Human Genome Sciences, Inc.,

2,

GlaxoSmithKline,

2;

G. Dennis,

Human Genome Sciences, Inc. ,

1,

Human Genome Sciences, Inc.,

3;

H. Kan,

GlaxoSmithKline,

1;

P. M. Jhingran,

GlaxoSmithKline,

3;

C. T. Molta,

GlaxoSmithKline,

1,

GlaxoSmithKline,

3;

G. Bao,
None;

C. Drenkard,

GlaxoSmithKline,

2,

Human Genome Sciences, Inc.,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/work-loss-in-systemic-lupus-erythematosus-the-general-public-and-other-chronic-conditions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology